Which pharmaceutical giant lost approximately $1.2 billion in market value after launching an arthritis drug with a name that, in Spanish, translated to 'little stick that gets lost'?

In the competitive pharmaceutical industry, advertising slogans and messaging can make or break a product's success. Some medical products have faced significant retail failures due to poor marketing decisions, resulting in dramatic financial consequences. This poll explores one of the most expensive marketing failures in medical product history, where a simple slogan choice had catastrophic results. Test your knowledge of pharmaceutical marketing history!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Pfizer (drug name: Celebrex)
Eli Lilly (drug name: Zyprexa)
Merck (drug name: Vioxx)
Novo Nordisk (drug name: Novorapid)